Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?
about
Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so farLoss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells.Role of afatinib in the treatment of advanced lung squamous cell carcinoma.Implications of KRAS mutations in acquired resistance to treatment in NSCLC.
P2860
Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Afatinib in the treatment of s ...... ew frontier or an old mistake?
@ast
Afatinib in the treatment of s ...... ew frontier or an old mistake?
@en
type
label
Afatinib in the treatment of s ...... ew frontier or an old mistake?
@ast
Afatinib in the treatment of s ...... ew frontier or an old mistake?
@en
prefLabel
Afatinib in the treatment of s ...... ew frontier or an old mistake?
@ast
Afatinib in the treatment of s ...... ew frontier or an old mistake?
@en
P2093
P2860
P50
P1476
Afatinib in the treatment of s ...... ew frontier or an old mistake?
@en
P2093
Claudia Proto
Giuseppe Lo Russo
Marina Chiara Garassino
P2860
P304
P356
10.3978/J.ISSN.2218-6751.2015.12.02
P577
2016-02-01T00:00:00Z